Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, reflecting a website update. The study record content remains unchanged.SummaryDifference0.1%

- Check13 days agoChange DetectedA banner announces an NIH website transition and says the agency is using “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry labeled Revision: v3.7.0 was added to the study record history, replacing the previous Revision: v3.6.6. This indicates a software update to the page rendering of the history section.SummaryDifference0.1%

- Check69 days agoChange DetectedThe record history shows a new revision, v3.6.6, replacing the previous v3.6.5. This reflects an internal version update in the page's history rather than a change to study information.SummaryDifference0.1%

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.